Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
155.34
+0.19 (+0.12%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,741,074
Open
154.68
Bid (Size)
155.10 (5)
Ask (Size)
155.80 (2)
Prev. Close
155.15
Today's Range
153.89 - 155.50
52wk Range
150.11 - 181.04
Shares Outstanding
2,628,679,824
Dividend Yield
3.06%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
October 03, 2023
All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration
Via
Benzinga
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories
October 03, 2023
Benzinga
Via
Benzinga
Performance
YTD
-12.82%
-12.82%
1 Month
-3.32%
-3.32%
3 Month
-4.59%
-4.59%
6 Month
-1.99%
-1.99%
1 Year
-4.82%
-4.82%
More News
Read More
Higher Rates, Lower Leverage: Growth Stocks To Struggle While AI Offers Hope, Goldman Sachs Analysts Say
October 03, 2023
Via
Benzinga
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Looking At Johnson & Johnson's Recent Unusual Options Activity
September 27, 2023
Via
Benzinga
(JNJ) - Analyzing Johnson & Johnson's Short Interest
September 25, 2023
Via
Benzinga
Pharma Giants Sanofi, Johnson & Johnson Join Forces To Develop E.coli Vaccine
October 03, 2023
Via
Benzinga
Johnson & Johnson Urged To Expand Access Tuberculosis Medication
October 02, 2023
Via
Benzinga
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
October 01, 2023
Via
The Motley Fool
Is Kenvue Stock Too Pricey to Buy?
September 30, 2023
Via
The Motley Fool
3 Magnificent Dividend Stocks to Buy in October
September 30, 2023
Via
The Motley Fool
Recession-Proof Royals: 3 Stocks That Thrive in Tough Economic Times
September 29, 2023
Via
InvestorPlace
Johnson & Johnson Unusual Options Activity
September 20, 2023
Via
Benzinga
Don’t Miss Out: 3 Dividend Stocks to Buy on EVERY. SINGLE. DIP.
September 29, 2023
Via
InvestorPlace
These 7 Dividend Stocks Pay $98 Billion Annually, Combined, to Their Shareholders
September 29, 2023
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 28, 2023
Via
Benzinga
Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs
September 28, 2023
Via
Benzinga
What's Going On Pfizer's Subsidiary Biohaven Stock?
September 27, 2023
Via
Benzinga
Why Immunovant Stock Is Bolting Higher Today
September 27, 2023
Via
The Motley Fool
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
September 27, 2023
Via
Benzinga
3 Things About Johnson & Johnson That Smart Investors Know
September 27, 2023
Via
The Motley Fool
2 Monster Stocks to Buy Without Any Hesitation
September 26, 2023
Via
The Motley Fool
3 Blue Chip Safe Havens to Shield Your Portfolio
September 25, 2023
Via
MarketBeat
Topics
ETFs
Economy
Exposures
Economy
Interest Rates
3 Reasons SharkNinja Is Swimming Toward New Highs
September 22, 2023
Via
MarketBeat
10 Health Care Stocks Whale Activity In Today's Session
September 21, 2023
Via
Benzinga
2 Incredibly Cheap Dividend Stocks to Buy Now
September 20, 2023
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.